predictXbio Inc
predictXbio provides an AI-driven platform for automating drug discovery to address antimicrobial resistance. The system uses advanced AI and machine learning, supported by bioinformatics pipelines and diverse datasets, to predict pathogen-drug interactions and the potency of existing and future antimicrobials. It can simulate in vitro lab tests to reduce time and cost compared to traditional experiments. The platform targets pharmaceutical companies and researchers, operating as a B2B SaaS offering focused on drug development and antimicrobial resistance solutions. It aims to scale by delivering data-driven insights and simulated data for future pathogens and therapeutic compounds.
predictXbio Inc
predictXbio provides an AI-driven platform for automating drug discovery to address antimicrobial resistance. The system uses advanced AI and machine learning, supported by bioinformatics pipelines and diverse datasets, to predict pathogen-drug interactions and the potency of existing and future antimicrobials. It can simulate in vitro lab tests to reduce time and cost compared to traditional experiments. The platform targets pharmaceutical companies and researchers, operating as a B2B SaaS offering focused on drug development and antimicrobial resistance solutions. It aims to scale by delivering data-driven insights and simulated data for future pathogens and therapeutic compounds.